Cargando…
Listeria monocytogenes Meningitis After Treatment With Infliximab in an 8-Year-Old Pediatric Patient With Crohn's Disease
Anti-tumor necrosis factor-alpha agents are used for the treatment of inflammatory bowel disease. Central nervous system infections are rare adverse effects of these medications, and to the best of our knowledge, there are only 2 case reports from the pediatric patient population. We report a case o...
Autores principales: | Rani, Uzma, Rana, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270588/ https://www.ncbi.nlm.nih.gov/pubmed/34258304 http://dx.doi.org/10.14309/crj.0000000000000624 |
Ejemplares similares
-
Immunocompromised Child on Infliximab: A Case Report of Listeria monocytogenes Meningitis
por: Halfman, Camille, et al.
Publicado: (2020) -
Listeria monocytogenes meningitis
por: Matsuo, Takahiro, et al.
Publicado: (2018) -
Sepsis and Meningitis due to Listeria Monocytogenes
por: Yildiz, Orhan, et al.
Publicado: (2007) -
Listeria Monocytogenes Meningitis in an Immunocompetent Patient
por: Magiar, Oana, et al.
Publicado: (2022) -
Listeria meningitis and resultant symptomatic hydrocephalus complicating infliximab treatment for ulcerative colitis
por: Rana, Fahd, et al.
Publicado: (2014)